CAMKMT and breast carcinoma: In addition to the inhibitors described above, other promising therapeutic agents such as histone methyltransferase (KMT) and histone demethylase (KDM)are being investigated in in vivo and in vitro studies for their potential in treating various types of cancers, including breast cancer.